Cargando…

Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome

Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassius, Charles, Le Buanec, Hélène, Bouaziz, Jean-David, Amode, Reyhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350546/
https://www.ncbi.nlm.nih.gov/pubmed/30766892
http://dx.doi.org/10.1155/2019/9141420
_version_ 1783390464889585664
author Cassius, Charles
Le Buanec, Hélène
Bouaziz, Jean-David
Amode, Reyhan
author_facet Cassius, Charles
Le Buanec, Hélène
Bouaziz, Jean-David
Amode, Reyhan
author_sort Cassius, Charles
collection PubMed
description Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity.
format Online
Article
Text
id pubmed-6350546
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63505462019-02-14 Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome Cassius, Charles Le Buanec, Hélène Bouaziz, Jean-David Amode, Reyhan J Immunol Res Review Article Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity. Hindawi 2019-01-14 /pmc/articles/PMC6350546/ /pubmed/30766892 http://dx.doi.org/10.1155/2019/9141420 Text en Copyright © 2019 Charles Cassius et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Cassius, Charles
Le Buanec, Hélène
Bouaziz, Jean-David
Amode, Reyhan
Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title_full Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title_fullStr Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title_full_unstemmed Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title_short Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome
title_sort biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350546/
https://www.ncbi.nlm.nih.gov/pubmed/30766892
http://dx.doi.org/10.1155/2019/9141420
work_keys_str_mv AT cassiuscharles biomarkersinadultdermatomyositistoolstohelpthediagnosisandpredicttheclinicaloutcome
AT lebuanechelene biomarkersinadultdermatomyositistoolstohelpthediagnosisandpredicttheclinicaloutcome
AT bouazizjeandavid biomarkersinadultdermatomyositistoolstohelpthediagnosisandpredicttheclinicaloutcome
AT amodereyhan biomarkersinadultdermatomyositistoolstohelpthediagnosisandpredicttheclinicaloutcome